ClinicalTrials.gg
RecruitingNCT02257723Updated Sep 28, 2023

The Effect of Integrated CAM Treatment in Hospitalized Patients

An observational study in Low Back Pain, Neck Pain and Knee Pain, sponsored by Jaseng Hospital of Korean Medicine. Recruiting at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2023-09-28.

Sponsored by Jaseng Hospital of Korean Medicine · Observational

How we know

From the registry’s dates

  • Started Jan 2012; still recruiting 14 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100,000
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 60 studies in Low Back Pain with a site in Korea, Republic of — 9 open to participants now, 11 under way, none of them phase 3. Low Back Pain · Korea, Republic of.

Planned enrollment
Largest of 12
100,000 · median 104
Started
2012
with 1 other
Observational
12 of 60
6 open now
Primary completion
2030-12
later than 10 of 10 live
Registered
19th of 60
by date

Among the 60 studies in Low Back Pain with a site in Korea, Republic of, this one has the largest planned enrollment of the 12 observational ones that give a count, is one of 2 that started in 2012, is one of 12 observational ones, reaches primary completion later than 10 of the 10 other live ones, and was the 19th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

9 of the 60 studies in Low Back Pain with a site in Korea, Republic of are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 60 studies in Low Back Pain with a site in Korea, Republic of, or all of them as a file.
02

Study summary

This study investigates the effect of hospital-based intensive non-surgical treatment in musculoskeletal patients admitted to an integrated hospital that offers both complementary and alternative medicine (CAM) and conventional medicine treatment.

Read the detailed description

This study investigates the effect of hospital-based intensive non-surgical treatment in musculoskeletal patients admitted to an integrated hospital that offers both complementary and alternative medicine (CAM) and conventional medicine treatment.

Inpatients received treatment according to a CAM treatment protocol (herbal medicine, acupuncture, bee venom pharmacopuncture, and Chuna manipulation) and conventional medicine treatment as needed. The main outcome measures were the duration of pain, NRS of back pain, radiating leg pain, neck pain, radiating arm pain, knee pain, shoulder pain, previous surgery, previous interventions (injections), Oswestry Disability Index (ODI), Vernon-Mior Neck Disability Index, the Korean Western Ontario McMaster Index, Shoulder Pain and Disability Index, range of motion (ROM), Straight leg raise test (SLR), alcohol use, smoking at admission, 2 weeks, and discharge.

03

Conditions studied

  • Low Back Pain
  • Neck Pain
  • Knee Pain
  • Shoulder Pain
  • Intervertebral Disc Herniation
  • Spinal Stenosis

Keywords

  • Inpatient care
  • Complementary and alternative medicine
  • Integrated medicine
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Musculoskeletal patients admitted to an integrated hospital that offers both complementary and alternative medicine (CAM) and conventional medicine treatment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients hospitalized due to spine or joint diseases

Exclusion criteria

Exclusion Criteria:

  • Main complaint other than back pain, radiating leg pain, neck pain, radiating arm pain, knee pain or shoulder pain
  • Cause of pain non-related to spine, joint or soft tissue; for example, spinal tumors, pregnancy, urolithiasis, etc.
  • Refusal to provide the information needed for clinical research
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100,000 participants (estimated)
Patient registry
No

Interventions

  • DrugHerbal medicine

    Herbal medicine was taken 3 times daily in dried powder (2g) and water-base decoction form (120ml) (Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes bidentata, Psoralea corylifolia, Peucedanum japonicum, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, and Atractylodes japonica).

    Also known as: Traditional herbal medicine

  • ProcedureAcupuncture

    Acupuncture treatment was administered 1-2 times daily using mainly Ah-shi points and local acupuncture points.

  • ProcedurePharmacopuncture

    Select ingredients similar to those included in the oral herbal medicine (Ostericum koreanum, Eucommia ulmoides, Acanthopanax Sessiliflorus, Achyranthes bidentata, Psoralea corylifolia, Peucedanum japonicum, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, and Atractylodes japonica) were freeze dried into powder form after decoction, then diluted in normal saline and adjusted for acidity and pH to be used in injections. The pharmacopuncture injections were injected once daily to the amount of 1 cc and Ah-shi points and local acupuncture points (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).

  • ProcedureBee venom pharmacopuncture

    Bee venom pharmacopuncture was applied after confirming a negative reaction to the hypersensitivity skin test. Diluted bee venom (saline:bee venom ratio, 10,000:1) was injected at 4-5 acupoints at the physician's discretion. Each acupuncture point was injected with approximately 0.2 cc to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).

  • ProcedureChuna manipulation

    Chuna was administered 3-5 times a week. Chuna is a Korean version of spinal manipulation that incorporates conventional spinal manipulation techniques for mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement.

06

What researchers measure

Primary outcomes

  1. NRS of low back pain (LBP)

    The patients were asked to quantify their current LBP, setting no pain as 0 and the most severe pain that they could possibly imagine as 10.

    Time frame: Admission (baseline), 2 weeks, Discharge

  2. NRS of radiating leg pain

    The patients were asked to quantify their current leg pain, setting no pain as 0 and the most severe pain that they could possibly imagine as 10.

    Time frame: Admission (baseline), 2 weeks, Discharge

  3. NRS of neck pain

    The patients were asked to quantify their current neck pain, setting no pain as 0 and the most severe pain that they could possibly imagine as 10.

    Time frame: Admission (baseline), 2 weeks, Discharge

  4. NRS of radiating arm pain

    The patients were asked to quantify their current radiating arm pain, setting no pain as 0 and the most severe pain that they could possibly imagine as 10.

    Time frame: Admission (baseline), 2 weeks, Discharge

  5. NRS of knee pain

    The patients were asked to quantify their current knee pain, setting no pain as 0 and the most severe pain that they could possibly imagine as 10.

    Time frame: Admission (baseline), 2 weeks, Discharge

  6. NRS of shoulder pain

    The patients were asked to quantify their current shoulder pain, setting no pain as 0 and the most severe pain that they could possibly imagine as 10.

    Time frame: Admission (baseline), 2 weeks, Discharge

  7. Oswestry disability index (ODI)

    The ODI is a survey assessing the patients' degree of functional disability in daily life consisting of 10 questions with 6 choices each corresponding to 0-5 points. The scores for each item are added, divided by 50, then multiplied by 100 to calculate the degree of disability. The Korean version of the ODI of which the reliability and validity have been verified through the research of Jeon et al. was used in this study.

    Time frame: Admission (baseline), 2 weeks, Discharge

  8. Vernon-Mior Neck Disability Index (NDI)

    NDI is a survey for evaluating disabilities that can be caused by neck pain in daily life performance. It consists of a total of 50 points by selecting a number from 0 to 5 for each item in 10 questions. The higher the score, the greater the daily disability.

    Time frame: Admission (baseline), 2 weeks, Discharge

  9. The Korean Western Ontario McMaster Index

    WOMAC is one of the most widely used indicators of the overall joint function score of the knee joint. A tool for evaluating disorders related to osteoarthritis of the lower extremities, including joints or knee joints. WOMAC consists of a total of 24 questions and three subscales. It consists of 5 questions about pain, 2 questions about stiffness, and 17 questions about difficulty in performing daily life related to the rest of the physical functions, so it is designed to measure the overall functional state of the joint.

    Time frame: Admission (baseline), 2 weeks, Discharge

  10. Shoulder Pain and Disability Index

    SPADI is a self-administered questionnaire that consists of two dimensions, one for pain and the other for functional activities. The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use.

    Time frame: Admission (baseline), 2 weeks, Discharge

Secondary outcomes

  1. Physical and neurological examinations

    The range of flexion and extension was assessed to objectively measure mobility, and straight leg raising (SLR), sensory function, muscle strength, and deep tendon reflex tests were conducted for neurological assessment.

    Time frame: Admission (baseline), 2 weeks, Discharge

Other outcomes

  1. Other baseline variables

    The duration of pain, previous surgery, previous interventions (injections), alcohol use, smoking

    Time frame: Admission (baseline)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Kim MH, Lee YJ, Shin JS, Lee J, Jeong H, Kim MR, Park SM, Go U, Kim SM, Kim JY, Hwang DG, Ha IH. The Long-Term Course of Outcomes for Lumbar Intervertebral Disc Herniation following Integrated Complementary and Alternative Medicine Inpatient Treatment: A Prospective Observational Study. Evid Based Complement Alternat Med. 2017;2017:5239719. doi: 10.1155/2017/5239719. Epub 2017 Aug 27. PubMed 28928789 ↗
  • Baek SH, Oh JW, Shin JS, Lee J, Lee YJ, Kim MR, Ahn YJ, Choi A, Park KB, Shin BC, Lee MS, Ha IH. Long term follow-up of cervical intervertebral disc herniation inpatients treated with integrated complementary and alternative medicine: a prospective case series observational study. BMC Complement Altern Med. 2016 Feb 4;16:52. doi: 10.1186/s12906-016-1034-z. PubMed 26850111 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2012 (actual). Primary completion is estimated for Dec 2030, 227 months after the start.

Of 177 non-industry observational studies under Low Back Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 227 months is above that.

Counting every sponsor, half of 187 studies reached it within 24 months; a quarter within 10 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2014
First posted
Oct 6, 2014
StartActual
Jan 2012
Primary completionEst.
Dec 2030
CompletionEst.
Dec 2040
Last update
Sep 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02257723
Lead sponsor
Jaseng Hospital of Korean Medicine
Responsible party
Sponsor
First posted
Oct 6, 2014
Start date
Jan 2012
Primary completion
Dec 2030 (estimated)
Completion
Dec 2040 (estimated)
Last update
Sep 28, 2023

Study contacts

In-Hyuk Ha, PhD
Contact
hanihata@gmail.com
+82 2 2222 2740
Me-riong Kim, Master
Contact
krmkmr@naver.com
+82 2 2222 2746
In-Hyuk Ha, PhD
principal investigator · Jaseng Medical Foundation

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion